Cormorant Asset Management Reduces Stake in Biomea Fusion, Inc.

Cormorant Asset Management, LP, along with its affiliated entities, has filed an amendment to its Schedule 13D, indicating a significant reduction in its stake in Biomea Fusion, Inc. The filing, dated October 24, 2025, reveals that the Reporting Persons sold a total of 2,620,872 shares of Common Stock in open-market transactions on October 22 and 23, 2025. The transactions were executed at prices ranging from $1.35 to $1.58 per share. As a result of these sales, the Reporting Persons' ownership in Biomea Fusion has decreased to 1.37% of the outstanding Common Stock, down from a previous holding of more than 5%. The filing also notes that Bihua Chen, a director of the Issuer, holds stock options that could increase her ownership stake. This amendment is the fourth update to the original Schedule 13D filed on April 30, 2021.